Factors associated with metabolic syndrome in administrative workers in the oil industry;Fatores associados à síndrome metabólica em trabalhadores administrativos de uma indústria de petróleo

Ciencia e Saude Coletiva

Volumn 16, Issue 8, 2011, Pages 3443-3452

  Felipe de Melo, Elizabeth Regina Torres ^a   da Silva, Rita de Cássia Ribeiro ^a   Assis, Ana Marlúcia Oliveira ^a   Pinto, Elisabete de Jesus ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Administrative workers; Associated factors; Metabolic syndrome; Oil industry

Indexed keywords

PETROLEUM;

ADMINISTRATIVE PERSONNEL; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MINING; OCCUPATIONAL HEALTH; RISK FACTOR;

ADMINISTRATIVE PERSONNEL; ADULT; AGED; CROSS-SECTIONAL STUDIES; EXTRACTION AND PROCESSING INDUSTRY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OCCUPATIONAL HEALTH; PETROLEUM; RISK FACTORS; YOUNG ADULT;

EID: 80052063952     PISSN: 14138123     EISSN: 16784561     Source Type: Journal    
DOI: 10.1590/S1413-81232011000900012     Document Type: Article

References (47)

1. DeFronzo R. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diab Rev 1997; 5:177-169.
2. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993; 44:121-131.
3. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149(7):1514-1520.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diab Rev 1988; 37(12): 1595-1607.
5. Ribeiro FFF, Mariosa LS, Ferreira SRG, Zanella MT. Gordura visceral e síndrome mebólica mais que uma simples associação. Arq Bras Endocrinol Metab 2006; 50(2):230-238.
6. Borges PK, Gimeno SG, Tomita NE, Ferreira SR. Prevalence and characteristics associated with metabolic syndrome in Japanese-Brazilians with and without periodontal disease. Cad Saude Publica 2007; 23(3):657-668.
7. Manna TD, Damian D, Setian N. Síndrome metabólica: revisão. Rev Paul Ped 2006; 28(4):272-277.
8. Saad MJ, Zanella MT, Ferreira SR. Metabolic syndrome: still undefined, but useful to identify high risk for cardiovascular disease. Arq Bras Endocrinol Metabol 2006; 50(2):161-162.
9. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care 2001; 24(4):683-689.
10. Strong K, Mathers C, Leeder SK, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet 2005; 366(9496):1578-1582.
11. Brasil. Ministério da Saúde. Taxa de mortalidade específica por doenças do aparelho circulatório. Brasília: Ministério da Saúde; 2008.
12. Couto HA, Vieira FLH, Lima EG. Estresse ocupacional e hipertensão arterial sistêmica. Rev Bras Hipertens 2007; 14(2):112-115.
13. Matos MFD. Prevalence of risk factors for cardiovascular disease in employees of the Research Center at Petrobras. Arq Bras Cardiol 2004; 82(1):1-4.
14. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ 2006; 332(7540):521-525.
15. Oberlinner C, Humpert PM, Nawroth PP, Zober A, Morcos M. Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample. Acta Diabetol 2008; 45(1):31-35.
16. Alegria E, Cordero A, Laclaustra M, Grima A, León M, Casasnovas JA, Luengo E, del Río A, Ferreira I. Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev Esp Cardiol 2005; 58(7):797-706.
17. Sanchez-Chaparro MA, Roman-Garcia J, Calvo-Bonacho E, Gómez-Larios T, Fernández-Meseguer A, Sáinz-Gutiérrez JC, Cabrera-Sierra M, García-García A, Rueda-Vicente J, Gálvez-Moraleda A. Prevalence of cardiovascular risk factors in the Spanish working population. Rev Esp Cardiol 2006; 59(5):421-430.
18. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Fernández-Labandera C, Cabrera M, Sáinz JC, Fernández-Meseguer A, Banegas JR, Ruilope LM, Valdivielso P, Román-García J. Occupation-related differences in the prevalence of metabolic syndrome. Diab Care 2008; 31(9):1884-1885.
19. Kuzuya M, Ando F, Iguchi A, Akihisa I, Hiroshi S. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis 2007; 191(2):305-312.
20. Simão M, Nogueira MS, Hayashida M, Cesarino EJ. Doenças cardiovasculares: perfil de trabalhadores do sexo masculino de uma destilaria do interior paulista. Rev Eletr Enferm 2002; 4(2):27-35.
21. SBC. Sociedade Brasileira de Cardiologia-I Diretriz Brasileira de diagnóstico e tratamento da Síndrome Metabólica. Arq Bras Cardiol 2005; 84(Supl.): 1-27.
22. Pontes LM, Souza MSC. Prevalência de excesso de peso, síndrome metabólica e seus components em futebolistas amadores. Fit Perf J 2007; 6(5):315-320.
23. Genuth S, Alberti K, Bennett P. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diab Care 2003; 26(11):3160-3167.
24. Veloso IS, Santana VS. Impact of the worker food program in Brazil. Rev Panam Salud Publica 2002; 11(1):24-31.
25. Babor T, Higgins-Biddle JC, Saunders JB, Monteiro M. AUDIT: the alcohol use disorders identification test. Guidelines for use in primary health care. Department of Mental Health and Substance Dependence. Geneva: World Health Organization; 2001.
26. Matsudo SM, Araújo T, Matsudo VR. Questionário Internacional de Atividade Física (IPAQ): estudo de validade e reprodutibilidade no Brasil. Rev Bras At Física & Saúde 2001; 6(2):5-18.
27. a ed. New York: John Wiley & Sons; 1989.
28. Barbieri MA, Bettiol H, Silva AA, Cardoso VC, Simões VMF, Gutierrez MRP, Castro JAS, Vianna ESO, Foss MC, dos Santos JE, Queiroz RGP. Health in early adulthood: the contribution of the 1978/79 Ribeirao Preto birth cohort. Braz J Med Biol Res 2006; 39(8):1041-1055.
29. Barbosa PJ, Lessa I, de Almeida Filho N, Magalhães LB, Araújo J. Criteria for central obesity in a Brazilian population: impact on metabolic syndrome. Arq Bras Cardiol 2006; 87(4):407-414.
30. Oliveira EP, de Souza ML, de Lima MD. Prevalence of metabolic syndrome in a semi-arid rural area in Bahia. Arq Bras Endocrinol Metabol 2006; 50(3):456-465.
31. Pousada JM, Britto MM, Cruz T, Lima Mde L, Lessa I, Lemaire DC, Carvalho RH, Martinez-Larrad MT, Torres EC, Serrano-Rios M. The metabolic syndrome in Spanish migrants to Brazil: unexpected results. Diab Res Clin Pract 2006; 72(1):75-80.
32. Salaroli LB, Barbosa GC, Mill JG, Molina MCB. Prevalence of metabolic syndrome in populationbased study, Vitoria, ES-Brazil. Arq Bras Endocrinol Metabol 2007; 51(7):1143-1152.
33. Freire RD, Shinzato AR, Cardoso MA, Gimeno SGA, Ferreira SRG. Dietary fat is associated with metabolic syndrome in population of Japanese ancestry. Diab Care 2005; 28(7):1779-1785.
34. Oh JY, Hong YS, Sung YA, Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diab Care 2004; 27(8):2027-2032.
35. Balkau B, Eschwege E. The metabolic syndrome. Lancet 2005; 366(9501):1921-1922.
36. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986; 44(6):739-746.
37. Oliveira A, Mancini Filho J. Perfil nutricional e lipídico de mulheres na pós-menopausa com doença arterial coronariana. Arq Bras Cardiol 2005; 84(4):325-329.
38. Hu G, Qiao Q, Tuomilehto J, Balkau, B; Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164(10):1066-1076.
39. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993; 14(1):72-93.
40. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21(6):697-638.
41. Matsuzawa Y, Nakamura T, Shimomura I, Kotami K. Visceral fat accumulation and cardiovascular disease. Obes Res 1995; 3(suppl 5):645S-647S.
42. Lee C, Jung J, Park E, Rhee EJ, Kim SW. Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diab Res Clin Pract 2005; 67(1):70-77.
43. Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health 2005; 43(2):295-301.
44. Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med 2007; 46(14):1079-1082.
45. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339(8802):1128-1130.
46. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J Intern Med 1993; 233(4):327-332.
47. Lee KS, Park CY, Meng KH, Bush A, Lee SH, Lee WC, Koo JW, Chung CK. The association of cigarette smoking and alcohol consumption with other cardiovascular risk factors in men from Seoul, Korea. Ann Epidemiol 1998; 8(1):31-38.